PRE-OP
LOE Approachinghexachlorophene
NDATOPICALSPONGE
Approved
Oct 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Clinical Trials (5)
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Started Sep 2025
50 enrolled
Soft Tissue Sarcoma
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
Started Feb 2024
90 enrolled
Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by Site+8 more
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Started Oct 2023
20 enrolled
Oropharynx Cancer, Stage I
Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
Started Jul 2022
0Breast CancerTriple Negative Breast Cancer
Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
Started Dec 2021
200 enrolled
Early Small (cT1N0) Triple Negative Breast Cancer
External Resources